Toxicity Profile of a Nutraceutical Formulation Derived from Green Mussel Perna viridis
Figure 1
(a) In vitro anti-inflammatory activities (COXI, II and LOXV inhibition activities) of the green mussel formulation compared with standard anti-inflammatory drugs, aspirin and indomethacin, at different concentrations (0.5, 1, and 5 mg/mL). (b) In vivo anti-inflammatory activity (% difference in paw edema compared to control group) of the green mussel formulation compared to standard anti-inflammatory drug, aspirin.
